Dra Consultants Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of DRA Consultants Ltd is ₹ 15 as of 16 Mar 09:49 . The P/E Ratio of DRA Consultants Ltd changed from 6.2 on March 2021 to 10.1 on March 2025 . This represents a CAGR of 10.25% over 5 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of DRA Consultants Ltd changed from ₹ 9.98 crore on March 2021 to ₹ 27.27 crore on March 2025 . This represents a CAGR of 22.27% over 5 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of DRA Consultants Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About DRA Consultants Ltd

DRA Consultants Limited was originally incorporated in Mumbai, as a proprietary firm in the year 1990, under the name and style of Dinesh Rathi and Associates.
Thereafter, a Company was formed by the Promoters, Dinesh Rathi and Uma Rathi, under the name and style of 'DRA Consultants Private Limited', on May 5, 2009, issued by Assistant Registrar of Companies.
Thereafter, Company acquired business of proprietary firm vide agreement dated June 30, 2009.
Subsequently, it converted into Public Limited Company, and the name was changed to 'DRA Consultants Limited'.
A fresh Certificate of Incorporation upon conversion from Private company to Public Company dated August 24, 2016, was issued by the Registrar of Companies. The Company is engaged mainly in the business of engineering consultancy in India.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of DRA Consultants Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, DRA Consultants Ltd or Sheel Biotech Ltd?

Market cap of DRA Consultants Ltd is 18 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of DRA Consultants Ltd and Sheel Biotech Ltd?

The stock performance of DRA Consultants Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for DRA Consultants Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the DRA Consultants Ltd stock price is INR ₹17.08. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of DRA Consultants Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of DRA Consultants Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.